New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 20, 2013
07:51 EDTCHEChemed price target raised to $91 from $80 at Oppenheimer
Oppenheimer increased its price target on Chemed after the company reported higher than expected Q4 EPS. The firm maintains an Outperform rating on the stock.
News For CHE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 23, 2014
08:35 EDTCHEChemed outlook positive, says Oppenheimer
After meeting with Chemed's executive management, Oppenheimer thinks the company's Vitas hospice unit is well-positioned for a rebound in 2H:14 and beyond, as admissions headwinds subside. The firm believes that the company's Roto-rooter unit should benefit from growth from water restoration and franchisee acquisitions, and it keeps an Outperform rating on the shares.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use